Regional anesthesia: Preferred technique for venodilatation in the creation of upper extremity arteriovenous fistulae

Vascular

Volumn 14, Issue 1, 2006, Pages 23-26

  Hingorani, Anil P ^a   Ascher, Enrico ^a   Gupta, Piyush ^a   Alam, Suhaila ^a   Marks, Natalie ^a   Schutzer, Richard W ^a   Multyala, Manykiam ^a   Shiferson, Alex ^a   Yorkovich, William ^a   Jacob, Theresa ^a   Salles Cunha, Sergio ^a  

^a MAIMONIDES MEDICAL CENTER   (United States)

Author keywords

Regional anesthesia; Upper extremity arteriovenous fistula

Indexed keywords

LIDOCAINE; ROPIVACAINE;

ADULT; AGED; ARTERIOVENOUS FISTULA; ARTICLE; BRACHIAL PLEXUS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG USE; ECHOGRAPHY; FEMALE; HEMATOMA; HUMAN; MALE; NERVE INJURY; PREVALENCE; PRIORITY JOURNAL; REGIONAL ANESTHESIA; TOURNIQUET; VEIN DILATATION;

ADULT; AGED; AGED, 80 AND OVER; AMIDES; ANESTHETICS, LOCAL; ARM; ARTERIOVENOUS SHUNT, SURGICAL; DIABETIC NEPHROPATHIES; DILATATION; ELECTRIC STIMULATION; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LIDOCAINE; MALE; MIDDLE AGED; NERVE BLOCK; RENAL DIALYSIS; VASODILATION;

EID: 33745712091     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.2310/6670.2006.00006     Document Type: Article

References (14)

1. http://www.kidney.org/professionals/kdoqi/guidelines_ updates/doqi_uptoc.html#va, national kidney foundation (accessed Mar 3, 2006).
2. Ascher E, Hingoran A, Gunduz Y, et al. The value and limitations of the arm cephalic and basilic vein for arteriovenous access. Ann Vasc Surg 2001;15:89-97.
3. Hingorani A, Ascher E, Kallakuri S, et al. Impact of reintervention for failing upper-extremity arteriovenous autogenous access for hemodialysis. J Vasc Surg 2001;34:1004-9.
4. Ascher E, Hingorani A. The Dialysis Outcome and Quality Initiative (DOQI) recommendations. Semin Vasc Surg 2004;17:3-9.
5. Ascher E, Gade P, Hingorani A, et al. Changes in the practice of angioaccess surgery: impact of dialysis outcome and quality initiative recommendations. J Vasc Surg 2000;31(1 Pt 1):84-92.
6. Sidawy AN, Gray R, Besarab A, et al. Recommended standards for reports dealing with arteriovenous hemodialysis accesses. J Vasc Surg 2002;35:603-10.
7. Rodriguez J, Quintela O, Lopez-Rivadulla M, et al. High doses of mepivacaine for brachial plexus block in patients with end-stage chronic renal failure. A pilot study. Eur J Anaesthesiol 2001;18: 171-6.
8. Cooper K, Kelley H, Carrithers J. Perceptions of side effects following axillary block used for outpatient surgery. Reg Anesth 1995;20:212-6.
9. Shemesh D, Zigelman C, Olsha O, et al. Primary forearm arteriovenous fistula for hemodialysis access-an integrated approach to improve outcomes. Cardiovasc Surg 2003;11:35-41.
10. Yeboah ED, Adu D, Anim-Addo Y, et al. Vascular access for haemodialysis for renal failure in a developing country. Trop Doct 1982;12(3):110-4.
11. Alsalti RA, el-Dawlatly AA, al-Salman M, et al. Arteriovenous fistula in chronic renal failure patients: comparison between three different anaesthetic techniques. Middle East J Anaesthesiol 1999;15:305-14.
12. Adnan T, Elif AA, Ayse K, Gulnaz A. Clonidine as an adjuvant for lidocaine in axillary brachial plexus block in patients with chronic renal failure. Acta Anaesthesiol Scand 2005;49:563-8.
13. Viscomi CM, Reese J, Rathmell JP. Medial and lateral antebrachial cutaneous nerve blocks: an easily learned regional anesthetic for forearm arteriovenous fistula surgery. Reg Anesth 1996;21:2-5.
14. Solomonson MD, Johnson ME, Ilstrup D. Risk factors in patients having surgery to create an arteriovenous fistula. Anesth Analg 1994;79:694-700.